ACOG Practice Bulletin No. 80: Premature rupture of membranes

Obstetrics and Gynecology

Volumn 109, Issue 4, 2007, Pages 1007-1019

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; ANTIBIOTIC AGENT; CORTICOSTEROID; ERYTHROMYCIN; UTERUS SPASMOLYTIC AGENT;

AMNIOCENTESIS; AMNIONITIS; BED REST; BODY MASS; CERCLAGE; CHORIOAMNIONITIS; CLINICAL TRIAL; CONNECTIVE TISSUE DISEASE; DELIVERY; ENTERIC COATED TABLET; ENTEROCOLITIS; FETUS MONITORING; HERPES SIMPLEX VIRUS 1; HOME CARE; HUMAN; LUNG DISEASE; MATERNAL SMOKING; NUTRITIONAL DEFICIENCY; OUTCOME ASSESSMENT; PRACTICE GUIDELINE; PREMATURE FETUS MEMBRANE RUPTURE; PREMATURITY; PRIORITY JOURNAL; RESPIRATORY DISTRESS SYNDROME; REVIEW; SOCIAL STATUS; UTERINE CERVIX CONIZATION; VALIDATION PROCESS; VIRUS INFECTION;

ANTIBIOTIC PROPHYLAXIS; FEMALE; FETAL MEMBRANES, PREMATURE RUPTURE; GESTATIONAL AGE; HEART RATE, FETAL; HUMANS; LABOR, INDUCED; PREGNANCY; PREMATURE BIRTH; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS AGALACTIAE;

EID: 34147094651     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.AOG.0000263888.69178.1f     Document Type: Review

References (103)

1. Goldenberg RL, Rouse DJ. Prevention of premature birth. N Engl J Med 1998;339:313-20. (Level III)
2. Mathews TJ, Mac Dorman MF. Infant mortality statistics from the 2003 period linked birth/infant death data set. Natl Vital Stat Rep 2006;54(16):1-29. (Level II-3)
3. Martin JA, Hamilton BE, Sutton PD, Ventura SJ, Menacker F, Kirmeyer S. Births: final data for 2004. Natl Vital Stat Rep 2006;5(1):1-101. (Level II-3)
4. Mercer BM. Preterm premature rupture of the membranes. Obstet Gynecol 2003;101:178-93. (Level III)
5. Lavery JP, Miller CE, Knight RD. The effect of labor on the rheologic response of chorioamniotic membranes. Obstet Gynecol 1982;60:87-92. (Level II-3)
6. McLaren J, Taylor DJ, Bell SC. Increased incidence of apoptosis in non-labour-affected cytotrophoblast cells in term fetal membranes overlying the cervix. Hum Reprod 1999;14:2895-900. (Level II-3)
7. El Khwad M, Stetzer B, Moore RM, Kumar D, Mercer B, Arikat S, et al. Term human fetal membranes have a weak zone overlying the lower uterine pole and cervix before onset of labor. Biol Reprod 2005;72:720-6. (Level II-3)
8. Moore RM, Mansour JM, Redline RW, Mercer BM, Moore JJ. The physiology of fetal membrane rupture: insight gained from the determination of physical properties. Placenta 2006;27:1037-51. (Level II-3).
9. Yoon BH, Romero R, Park JS, Kim CJ, Kim SH, Choi JH, et al. Fetal exposure to an intra-amniotic inflammation and the development of cerebral palsy at the age of three years. Am J Obstet Gynecol 2000;182:675-81. (Level II-3)
10. Harger JH, Hsing AW, Tuomala RE, Gibbs RS, Mead PB, Eschenbach DA, et al. Risk factors for preterm premature rupture of fetal membranes: a multicenter case-control study. Am J Obstet Gynecol 1990;163:130-7. (Level II-2)
11. Taylor J, Garite TJ. Premature rupture of membranes before fetal viability. Obstet Gynecol 1984;64:615-20. (Level II-3)
12. Mercer BM, Goldenberg RL, Meis PJ, Moawad AH, Shellhaas C, Das A, et al. The Preterm Prediction Study: prediction of preterm premature rupture of membranes using clinical findings and ancillary testing. The National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. Am J Obstet Gynecol 2000;183:738-45. (Level II-2)
13. Minkoff H, Grunebaum AN, Schwarz RH, Feldman J, Cummings M, Crombleholme W, et al. Risk factors for prematurity and premature rupture of membranes: a prospective study of the vaginal flora in pregnancy. Am J Obstet Gynecol 1984;150:965-72. (Level II-2)
14. Naeye RL. Factors that predispose to premature rupture of the fetal membranes. Obstet Gynecol 1982;60:93-8. (Level II-3)
15. Naeye RL, Peters EC. Causes and consequences of premature rupture of fetal membranes. Lancet 1980;1:192-4. (Level II-3)
16. Charles D, Edwards WR. Infectious complications of cervical cerclage. Am J Obstet Gynecol 1981;141:1065-71. (Level II-3)
17. Hadley CB, Main DM, Gabbe SG. Risk factors for preterm premature rupture of the fetal membranes. Am J Perinatol 1990;7:374-9. (Level II-2)
18. Siega-Riz AM, Promislow JH, Savitz DA, Thorp JM Jr, McDonald T. Vitamin C intake and the risk of preterm delivery. Am J Obstet Gynecol 2003;189:519-25. (Level II-2)
19. Gold RB, Goyert GL, Schwartz DB, Evans MI, Seabolt LA. Conservative management of second-trimester post-amniocentesis fluid leakage. Obstet Gynecol 1989;74:745-7. (Level II-3)
20. Lee T, Carpenter M, Heber WW, Silver HM. Preterm premature rupture of membranes: risks of recurrent complications in the next pregnancy among a population-based sample of gravid women. Am J Obstet Gynecol 2003;188:209-13. (Level II-2)
21. Asrat T, Lewis DF, Garite TJ, Major CA, Nageotte MP, Towers CV, et al. Rate of recurrence of preterm premature rupture of membranes in consecutive pregnancies. Am J Obstet Gynecol 1991;165:1111-5. (Level III)
22. Guinn DA, Goldenberg RL, Hauth JC, Andrews WW, Thom E, Romero R. Risk factors for the development of preterm premature rupture of the membranes after arrest of preterm labor. Am J Obstet Gynecol 1995;173:1310-5. (Level II-2)
23. Meis PJ, Klebanoff M, Thom E, Dombrowski MP, Sibai B, Moawad AH, et al. Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate. National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network [published erratum appears in N Engl J Med 2003;349:1299]. N Engl J Med 2003;348:2379-85. (Level I)
24. da Fonseca EB, Bittar RE, Carvalho MH, Zugaib M. Prophylactic administration of progesterone by vaginal suppository to reduce the incidence of spontaneous preterm birth in women at increased risk: a randomized placebo-controlled double-blind study. Am J Obstet Gynecol 2003;188:419-24. (Level I)
25. Hannah ME, Ohlsson A, Farine D, Hewson SA, Hodnett ED, Myhr TL, et al. Induction of labor compared with expectant management for prelabor rupture of the membranes at term. TERMPROM Study Group. N Engl J Med 1996;334:1005-10. (Level I)
26. Wagner MV, Chin VP, Peters CJ, Drexler B, Newman LA. A comparison of early and delayed induction of labor with spontaneous rupture of membranes at term. Obstet Gynecol 1989;74:93-7. (Level II-1)
27. Guise JM, Duff P, Christian JS. Management of term patients with premature rupture of membranes and an unfavorable cervix. Am J Perinatol 1992;9:56-60. (Level II-2)
28. Johnson JW, Egerman RS, Moorhead J. Cases with ruptured membranes that "reseal." Am J Obstet Gynecol 1990;163:1024-30; discussion 1030-2. (Level II-2)
29. Novak-Antolic Z, Pajntar M, Verdenik I. Rupture of the membranes and postpartum infection. Eur J Obstet Gynecol Reprod Biol 1997;71:141-6. (Level II-3)
30. Eddleman K, Malone F, Sullivan L, Dukes K, Berkowitz R, Kharbutli Y, et al. Pregnancy loss rates after mid-trimester amniocentesis. Obstet Gynecol 2006;108:1067-72. (Level II-2)
31. Borgida AF, Mills AA, Feldman DM, Rodis JF, Egan JF. Outcome of pregnancies complicated by ruptured membranes after genetic amniocentesis. Am J Obstet Gynecol 2000;183:937-9. (Level II-3)
32. Gold RB, Goyert GL, Schwartz DB, Evans MI, Seabolt LA. Conservative management of second trimester post-amniocentesis fluid leakage. Obstet Gynecol 1989;74:745-7. (Level II-3).
33. Mercer BM. Management of premature rupture of membranes before 26 weeks' gestation. Obstet Gynecol Clin North Am 1992;19:339-51. (Level III)
34. Beydoun SN, Yasin SY. Premature rupture of the membranes before 28 weeks: conservative management. Am J Obstet Gynecol 1986;155:471-9. (Level II-3)
35. Garite TJ, Freeman RK. Chorioamnionitis in the preterm gestation. Obstet Gynecol 1982;59:539-45. (Level II-3)
36. Simpson GF, Harbert GM Jr. Use of beta-methasone in management of preterm gestation with premature rupture of membranes. Obstet Gynecol 1985;66:168-75. (Level II-2)
37. Vergani P, Ghidini A, Locatelli A, Cavallone M, Ciarla I, Cappellini A. Risk factors for pulmonary hypoplasia in second-trimester premature rupture of membranes. Am J Obstet Gynecol 1994;170:1359-64. (Level II-3)
38. Hillier SL, Martius J, Krohn M, Kiviat N, Holmes KK, Eschenbach DA. A case-control study of chorioamnionic infection and histologic chorioamnionitis in prematurity. N Engl J Med 1988;319:972-8. (Level II-2)
39. Morales WJ. The effect of chorioamnionitis on the developmental outcome of preterm infants at one year. Obstet Gynecol 1987;70:183-6. (Level II-3)
40. Alexander JM, Mercer BM, Miodovnik M, Thurnau GR, Goldenberg RL, Das AF, et al. The impact of digital cervical examination on expectantly managed preterm rupture of membranes. Am J Obstet Gynecol 2000;183(4):1003-7. (Level II-3)
41. Ananth CV, Savitz DA, Williams MA. Placental abruption and its association with hypertension and prolonged rupture of membranes: a methodologic review and metaanalysis. Obstet Gynecol 1996;88:309-18. (Meta-analysis)
42. Gonen R, Hannah ME, Milligan JE. Does prolonged preterm premature rupture of the membranes predispose to abruptio placentae? Obstet Gynecol 1989;74:347-50. (Level II-2)
43. Mercer BM, Arheart KL. Antimicrobial therapy in expectant management of preterm premature rupture of the membranes [published erratum appears in Lancet 1996;347:410]. Lancet 1995;346:1271-9. (Meta-analysis)
44. Lemons JA, Bauer CR, Oh W, Korones SB, Papile LA, Stoll BJ, et al. Very low birth weight outcomes of the National Institute of Child Health and Human Development Neonatal Research Network, January 1995 through December 1996. NICHD Neonatal Research Network. Pediatrics 2001;107:E1. (Level II-2)
45. Spinillo A, Capuzzo E, Stronati M, Ometto A, Orcesi S, Fazzi E. Effect of preterm premature rupture of membranes on neurodevelopmental outcome: follow up at two years of age. Br J Obstet Gynaecol 1995;102:882-7. (Level II-3)
46. Locatelli A, Ghidini A, Paterlini G, Patane L, Doria V, Zorloni C, et al. Gestational age at preterm premature rupture of membranes: a risk factor for neonatal white matter damage. Am J Obstet Gynecol 2005;193:947-51. (Level II-3)
47. Schucker JL, Mercer BM. Midtrimester premature rupture of the membranes. Semin Perinatol 1996;20:389-400. (Level III)
48. Dewan H, Morris JM. A systematic review of pregnancy outcome following preterm premature rupture of membranes at a previable gestational age. Aust N Z J Obstet Gynaecol 2001;41:389-94. (Meta-analysis)
49. Bengtson JM, VanMarter LJ, Barss VA, Greene MF, Tuomala RE, Epstein MF. Pregnancy outcome after premature rupture of the membranes at or before 26 weeks' gestation. Obstet Gynecol 1989;73:921-7. (Level II-3)
50. Cox SM, Leveno KJ. Intentional delivery versus expectant management with preterm ruptured membranes at 30-34 weeks' gestation. Obstet Gynecol 1995;86:875-9. (Level I)
51. Mercer BM, Crocker LG, Boe NM, Sibai BM. Induction versus expectant management in premature rupture of the membranes with mature amniotic fluid at 32 to 36 weeks: a randomized trial. Am J Obstet Gynecol 1993;169:775-82. (Level I)
52. Moretti M, Sibai BM. Maternal and perinatal outcome of expectant management of premature rupture of the membranes in the midtrimester. Am J Obstet Gynecol 1988;159:390-6. (Level II-3)
53. Rotschild A, Ling EW, Puterman ML, Farquharson D. Neonatal outcome after prolonged preterm rupture of the membranes. Am J Obstet Gynecol 1990;162:46-52. (Level II-3)
54. van Eyck J, van der Mooren K, Wladimiroff JW. Ductus arteriosus flow velocity modulation by fetal breathing movements as a measure of fetal lung development. Am J Obstet Gynecol 1990;163:558-66. (Level II-3)
55. Winn HN, Chen M, Amon E, Leet TL, Shumway JB, Mostello D. Neonatal pulmonary hypoplasia and perinatal mortality in patients with midtrimester rupture of amniotic membranes - a critical analysis. Am J Obstet Gynecol 2000;182:1638-44. (Level II-2)
56. Shumway J, Al-Malt A, Amon E, Cohlan B, Amini S, Abboud M, et al. Impact of oligohydramnios on maternal and perinatal outcomes of spontaneous premature rupture of the membranes at 18-28 weeks. J Matern Fetal Med 1999;8:20-3. (Level II-2)
57. Munson LA, Graham A, Koos BJ, Valenzuela GJ. Is there a need for digital examination in patients with spontaneous rupture of the membranes? Am J Obstet Gynecol 1985;153:562-3. (Level II-3)
58. Brown CL, Ludwiczak MH, Blanco JD, Hirsch CE. Cervical dilation: accuracy of visual and digital examinations. Obstet Gynecol 1993;81:215-6. (Level II-2)
59. Lewis DF, Major CA, Towers CV, Asrat T, Harding JA, Garite TJ. Effects of digital vaginal examinations on latency period in preterm premature rupture of membranes. Obstet Gynecol 1992;80:630-4. (Level II-3)
60. American College of Obstetricians and Gynecologists. Prevention of early-onset group B streptococcal disease in newborns. ACOG Committee Opinion No. 289. Obstet Gynecol 2002;100:1405-12. (Level III)
61. Smith CV, Greenspoon J, Phelan JP, Platt LD. Clinical utility of the nonstress test in the conservative management of women with preterm spontaneous premature rupture of the membranes. J Reprod Med 1987;32:1-4. (Level II-3)
62. Hanley ML, Vintzileos AM. Biophysical testing in premature rupture of the membranes. Semin Perinatol 1996;20:418-25. (Level III)
63. Naef RW 3rd, Allbert JR, Ross EL, Weber BM, Martin RW, Morrison JC. Premature rupture of membranes at 34 to 37 weeks' gestation: aggressive versus conservative management. Am J Obstet Gynecol 1998;178:126-30. (Level I)
64. Neerhof MG, Cravello C, Haney EI, Silver RK. Timing of labor induction after premature rupture of membranes between 32 and 36 weeks' gestation. Am J Obstet Gynecol 1999;180:349-52. (Level II-3)
65. Mercer BM, Miodovnik M, Thurnau GR, Goldenberg RL, Das AF, Ramsey RD, et al. Antibiotic therapy for reduction of infant morbidity after preterm premature rupture of the membranes. A randomized controlled trial. National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. JAMA 1997;278:989-95. (Level I)
66. Mercer BM, Rabello YA, Thurnau GR, Miodovnik M, Goldenberg RL, Das AF, et al. The NICHD-MFMU antibiotic treatment of preterm PROM study: impact of initial amniotic fluid volume on pregnancy outcome. NICHD-MFMU Network. Am J Obstet Gynecol 2006;194:438-45. (Level II-2)
67. Tsoi E, Fuchs I, Henrich W, Dudenhausen JW, Nicolaides KH. Sonographic measurement of cervical length in preterm prelabor amniorrhexis. Ultrasound Obstet Gynecol 2004;24:550-3. (Level II-3)
68. Rizzo G, Capponi A, Angelini E, Vlachopoulou A, Grassi C, Romanini C. The value of transvaginal ultrasonographic examination of the uterine cervix in predicting preterm delivery in patients with preterm premature rupture of membranes. Ultrasound Obstet Gynecol 1998;11:23-9. (Level II-2)
69. Carlan SJ, Richmond LB, O'Brien WF. Randomized trial of endovaginal ultrasound in preterm premature rupture of membranes. Obstet Gynecol 1997;89:458-61. (Level I)
70. Christensen KK, Ingemarsson I, Leideman T, Solum H, Svenningsen N. Effect of ritodrine on labor after premature rupture of the membranes. Obstet Gynecol 1980;55:187-90. (Level I)
71. Levy DL, Warsof SL. Oral ritodrine and preterm premature rupture of membranes. Obstet Gynecol 1985;66:621-3. (Level II-1)
72. Weiner CP, Renk K, Klugman M. The therapeutic efficacy and cost-effectiveness of aggressive tocolysis for premature labor associated with premature rupture of the membranes [published erratum appears in Am J Obstet Gynecol 1991;165:785]. Am J Obstet Gynecol 1988;159:216-22. (Level I)
73. Garite TJ, Keegan KA, Freeman RK, Nageotte MP. A randomized trial of ritodrine tocolysis versus expectant management in patients with premature rupture of membranes at 25 to 30 weeks of gestation. Am J Obstet Gynecol 1987;157:388-93. (Level II-1)
74. Combs CA, McCune M, Clark R, Fishman A. Aggressive tocolysis does not prolong pregnancy or reduce neonatal morbidity after preterm premature rupture of the membranes. Am J Obstet Gynecol 2004;190:1723-8; discussion 1728-31. (Level I)
75. Wolfensberger A, Zimmermann R, von Mandach U. Neonatal mortality and morbidity after aggressive longterm tocolysis for preterm premature rupture of the membranes. Fetal Diagn Ther 2006;21:366-73. (Level II-2)
76. Wright LL, Verter J, Younes N, Stevenson D, Fanaroff AA, Shankaran S, et al. Antenatal corticosteroid administration and neonatal outcome in very low birth weight infants: the NICHD Neonatal Research Network. Am J Obstet Gynecol 1995;173:269-74. (Level II-3)
77. Antenatal corticosteroids revisited: repeat courses - National Institutes of Health Consensus Development Conference Statement, August 17-18, 2000. National Institutes of Health Consensus Development Panel. Obstet Gynecol 2001;98:144-50. (Level III)
78. Antenatal corticosteroid therapy for fetal maturation. ACOG Committee Opinion No. 273. American College of Obstetricians and Gynecologists. Obstet Gynecol 2002;99:871-3. (Level III)
79. Ohlsson A. Treatments of preterm premature rupture of the membranes: a meta-analysis. Am J Obstet Gynecol 1989;160:890-906. (Meta-analysis)
80. Crowley PA. Antenatal corticosteroid therapy: a meta-analysis of the randomized trials, 1972 to 1994. Am J Obstet Gynecol 1995;173:322-35. (Meta-analysis)
81. Lovett SM, Weiss JD, Diogo MJ, Williams PT, Garite TJ. A prospective, double-blind, randomized, controlled clinical trial of ampicillin-sulbactam for preterm premature rupture of membranes in women receiving antenatal corticosteroid therapy. Am J Obstet Gynecol 1997;176:1030-8. (Level I)
82. Roberts D, Dalziel S. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database of Systematic Reviews 2006, Issue 3. Art. No.: CD004454. DOI: 10.1002/14651858. CD004454.pub2. (Meta-analysis)
83. Harding JE, Pang J, Knight DB, Liggins GC. Do antenatal corticosteroids help in the setting of preterm rupture of membranes? Am J Obstet Gynecol 2001;184:131-9. (Meta-analysis)
84. Lewis DF, Brody K, Edwards MS, Brouillette RM, Burlison S, London SN. Preterm premature ruptured membranes: a randomized trial of steroids after treatment with antibiotics. Obstet Gynecol 1996;88:801-5. (Level I)
85. Pattinson RC, Makin JD, Funk M, Delport SD, Macdonald AP, Norman K, et al. The use of dexamethasone in women with preterm premature rupture of membranes - a multicentre, double-blind, placebo-controlled, randomised trial. Dexiprom Study Group. S Afr Med J 1999;89:865-70. (Level I)
86. Egarter C, Leitich H, Karas H, Wieser F, Husslein P, Kaider A, et al. Antibiotic treatment in premature rupture of membranes and neonatal morbidity: a metaanalysis. Am J Obstet Gynecol 1996;174:589-97. (Meta-analysis)
87. Kenyon S, Boulvain M, Neilson J. Antibiotics for preterm rupture of membranes. Cochrane Database of Systematic Reviews 2003, Issue 2. Art No.: CD001058. DOI: 10. 1002/14651858.CD001058. (Meta-analysis)
88. Kenyon SL, Taylor DJ, Tarnow-Mordi W. Broad spectrum antibiotics for preterm, prelabor rupture of fetal membranes: the ORACLE I randomized trial. ORACLE Collaborative Group [published erratum appears in Lancet 2001;358:156]. Lancet 2001;357:979-88. (Level I)
89. Lewis DF, Adair CD, Robichaux AG, Jaekle RK, Moore JA, Evans AT, et al. Antibiotic therapy in preterm premature rupture of membranes: are seven days necessary? A preliminary, randomized clinical trial. Am J Obstet Gynecol 2003;188:1413-6; discussion 1416-7. (Level I)
90. Segel SY, Miles AM, Clothier B, Parry S, Macones GA. Duration of antibiotic therapy after preterm premature rupture of fetal membranes. Am J Obstet Gynecol 2003;189:799-802. (Level I)
91. Carlan SJ, O'Brien WF, Parsons MT, Lense JJ. Preterm premature rupture of membranes: a randomized study of home versus hospital management. Obstet Gynecol 1993;81:61-4. (Level I)
92. Blickstein I, Katz Z, Lancet M, Molgilner BM. The outcome of pregnancies complicated by preterm rupture of the membranes with and without cerclage. Int J Gynaecol Obstet 1989;28:237-42. (Level II-3)
93. Yeast JD, Garite TR. The role of cervical cerclage in the management of preterm premature rupture of the membranes. Am J Obstet Gynecol 1988;158:106-10. (Level II-3)
94. Ludmir J, Bader T, Chen L, Lindenbaum C,Wong G. Poor perinatal outcome associated with retained cerclage in patients with premature rupture of membranes. Obstet Gynecol 1994;84:823-6. (Level II-3)
95. Jenkins TM, Berghella V, Shlossman PA, McIntyre CJ, Maas BD, Pollock MA, et al. Timing of cerclage removal after preterm premature rupture of membranes: maternal and neonatal outcomes. Am J Obstet Gynecol 2000;183:847-52. (Level II-3)
96. McElrath TF, Norwitz ER, Lieberman ES, Heffner LJ. Perinatal outcome after preterm premature rupture of membranes with in situ cervical cerclage. Am J Obstet Gynecol 2002;187:1147-52. (Level II-3)
97. Kuhn RJ, Pepperell RJ. Cervical ligation: a review of 242 pregnancies. Aust N Z J Obstet Gynecol 1977;17:79-83. (Level II-3)
98. Chuang T. Neonatal herpes: incidence, prevention, and consequences. Am J Prev Med 1988;4:47-53. (Level III)
99. Amstey MS. Management of pregnancy complicated by genital herpes virus infection. Obstet Gynecol 1971;37:515-20. (Level II-3)
100. Nahmias AJ, Josey WE, Naib ZM, Freeman MG, Fernandez RJ, Wheeler JH. Perinatal risk associated with maternal genital herpes simplex virus infection. Am J Obstet Gynecol 1971;110:825-37. (Level II-3)
101. Gibbs RS, Amstey MS, Lezotte DC. Role of cesarean delivery in preventing neonatal herpes virus infection. JAMA 1993;270:94-5. (Level III)
102. Major CA, Towers CV, Lewis DF, Garite TJ. Expectant management of preterm premature rupture of membranes complicated by active recurrent genital herpes. Am J Obstet Gynecol 2003;188:1551-4; discussion 1554-5. (Level II-3)
103. Perinatal care at the threshold of viability. ACOG Practice Bulletin No. 38. American College of Obstetricians and Gynecologists. Obstet Gynecol 2002;100:617-24. (Level III)